LEEDS, England--(BUSINESS WIRE)--Tissue Regenix Group plc (AIM:TRX) (“Tissue Regenix”) or (“The Group”) the regenerative medical devices company, will this week display nine clinical poster presentations at the Symposium on Advanced Wound Care (SAWC) Spring conference held in Atlanta, Georgia.
The nine posters written by key opinion leaders from both clinical and research settings, demonstrate further evidence for the use of DermaPure®, a decellurised dermal allograft, which utilises The Groups patented dCELL® technology, in varying wound care settings.
